Search - tctmd.com

Displaying 321 - 340 of 490

Sort: Relevancy | Date

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Presenter: Piotr Buszman

October 28, 2013

Presentation TCT 2013

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Presenter: Michael Haude

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

Presentation

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Presenter: F. Liistro

October 14, 2013

News Industry News

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

October 09, 2013

News Daily News

Un Balón liberador de Fármacos Supera a la Angioplastia en el Tratamiento de la Reestenosis intra Stent

Jason Kahn

September 27, 2013

News Daily News

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

Jason Kahn

September 27, 2013

Presentation

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

Presenter: Seiji Habara

September 23, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Advertisement

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Boston Scientific Begins Clinical Trial Of Innova™ Peripheral Vascular Drug-Eluting Stent System

Un Balón liberador de Fármacos Supera a la Angioplastia en el Tratamiento de la Reestenosis intra Stent

Drug-eluting Balloon Bests Angioplasty for In-stent Restenosis

A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content